You are here: All Products  > Harbour BioMed Out-Licenses US Rights for Bispecific in $588 Million Deal

Harbour BioMed Out-Licenses US Rights for Bispecific in $588 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products